Defense Buffeted By Tough Rulings In Valeant Kickback Trial

Law360, New York (May 15, 2018, 8:49 PM EDT) -- Two men who are charged with defrauding Valeant Pharmaceuticals International Inc. out of $9.7 million when it bought an option to acquire Philidor Rx Services LLC were dealt a bad hand by a Manhattan federal judge on Tuesday, with the court rejecting their efforts to have one of Valeant’s lawyers testify and to prevent an FBI agent from undercutting their arguments.

Former Valeant manager Gary Tanner and ex-Philidor CEO Andrew Davenport had sought to lay a foundation for testimony from Michael Hess, an outside lawyer for...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.